On ECHEMI
Home > Drugs > Primary monoclonal gammopathy
Primary monoclonal gammopathy
Primary monoclonal gammopathy is characterized by limited increase in monoclonal immunoglobulin levels and no clinical symptoms in patients without malignant plasma cell disease or diseases that can cause increased immunoglobulin levels.
  • Site of disease:

    whole body
  • Infectious :

    Not contagious
  • Frequent population:

    Elderly population
  • Related symptoms:

    Increased bone marrow plasma cells Serum immunoglobulin may increase ESR rate Heterogeneous protein reaction Heterogeneous protein reaction
  • Concurrent disease:

Related Drugs
Thymosin enteric-coated tablets
Indication: Chronic hepatitis B, T cell deficiency, autoimmune diseases, immunocompromised diseases, adjuvant therapy for tumors
Manufacturer:

Harbin Xinnongda Food Co., Ltd.

Thymosin enteric-coated tablets
Indication: 1 For patients with chronic hepatitis B. 2 Various primary or secondary T-cell deficiency diseases (such as congenital immunodeficiency in children). 3 Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, childhood bronchial asthma and asthmatic bronchitis, etc.). 4 Various diseases with low cellular immune function (such as viral hepatitis, prevention of upper respiratory tract infection, stubborn oral ulcers, etc.). 5 Adjuvant treatment of tumors.
Manufacturer:

Jilin Connell Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.